Filter
542
Filtered Results: 542
Text search:
Rational
Pharmaceutical
Management
Project
Featured
Recommendations
47
New Publications
178
Language
Document type
No document type
313
Studies & Reports
91
Guidelines
70
Strategic & Response Plan
23
Manuals
20
Training Material
13
Situation Updates
7
Fact sheets
4
Brochures
1
Countries / Regions
Kenya
30
Ethiopia
26
India
19
Zambia
17
Uganda
16
Global
15
Sierra Leone
14
Nigeria
14
Western and Central Europe
14
Liberia
13
Ghana
11
Rwanda
11
Tanzania
10
Namibia
10
Philippines
9
Nepal
9
Malawi
8
Eastern Europe
8
Cambodia
6
South Africa
6
Eswatini/ Swaziland
6
Myanmar / Burma
6
Indonesia
5
Bangladesh
5
Lesotho
5
Zimbabwe
4
Latin America and the Carribbean
4
Africa
4
Congo, Democratic Republic of
3
Cameroon
3
South Sudan
3
Thailand
3
Ukraine
3
Botswana
3
South–East Asia Region
3
Eastern Europe and Central Asia
3
Asia
3
Haiti
2
Jordan
2
Germany
2
Mozambique
2
Vietnam
2
Burkina Faso
1
Senegal
1
Mali
1
USA
1
Pakistan
1
Syria
1
China
1
Sudan
1
Benin
1
Central African Republic
1
Peru
1
North Macedonia
1
Libya
1
Western Pacific Region
1
Albania
1
Laos
1
Tajikistan
1
Russia
1
Gabon
1
Turkmenistan
1
Belgium
1
Authors & Publishers
Publication Years
Category
Countries
259
Public Health
30
Clinical Guidelines
28
Key Resources
24
Women & Child Health
9
Pharmacy & Technologies
9
Capacity Building
4
Annual Report MEDBOX
2
Toolboxes
AMR
83
Pharmacy
48
TB
34
Mental Health
19
HIV
15
NCDs
14
Rapid Response
12
COVID-19
11
Planetary Health
11
Global Health Education
10
NTDs
9
Caregiver
7
Ebola
4
Conflict
3
Natural Hazards
3
Refugee
3
Health Financing Toolbox
3
Disability
2
Polio
2
Zika
1
Specific Hazards
1
This policy brief aims to provide a review of the current progress on implementing the Kenya national action plan on AMR, identifies critical gaps, and highlights findings to accelerate further progress in the human health sector. The target audience includes all those concerned with implementing ac...
Consultancy to take forward the International Health Partnership
This global guidance provided the framework for over 100 countries to develop their NDVPs. This updated (second) version supersedes the previous version published in 16 November 2020. New information has been added on the following areas:
the COVID-19 Partners Platform;
the use of COVID...
The revised package of BFHI materials includes five sections: 1. Background and Implementation, 2. Strengthening and Sustaining the BFHI: A course for decision-makers, 3. Breastfeeding Promotion and Support in a Baby-friendly Hospital: a 20-hour course for maternity staff, 4. Hospital Self-Appraisal...
Coordinated Use of Anthelminthic Drugs in Control Interventions: a Manual for Health Professionals and Programme Managers
These Guidelines comprise a General Guidelines document that provides the basic parameters of DG ECHO humanitarian health assistance, complemented by specific Technical Guidance in annex.
Guidance on TB and TB/HIV prevention, diagnosis, treatment and care in the workplace
Introduction, preparations to submit, submission procedure, requirements, main narrative of the protocol, definition of terms. | For Research and ethics clearance in Lesotho
The new WHO recommendations for the treatment of isoniazid-resistant, rifampicin-susceptible TB are based upon a review of evidence from patients treated with such regimens by a Guideline Development Group in conformity with WHO requirements for evidence-based policies.
Regional Network for Equity in Health in east and southern Africa (EQUINET): Disussion Paper 110
This report compiles evidence from published, grey literature and key informants on the UNMHCP since its introduction in Uganda’s health system, and findings were further validated during a oneda...
This report compiles evidence from published, grey literature and key informants on the UNMHCP since its introduction in Uganda’s health system, and findings were further validated during a oneda...
In 2017, 3.6 million of the estimated 10 million people with TB worldwide were “missed” by national TB programmes (NTPs). Two thirds of them are thought to access TB treatment of questionable quality from public and private providers who are not engaged by the NTP. The quality of care provided i...
